LINC00982-encoded protein PRDM16-DT regulates CHEK2 splicing to suppress colorectal cancer metastasis and chemoresistance
Theranostics · 2024
DOI: 10.7150/thno.95485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Hui-Fang Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, College of Life Science an…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, DNA-Binding Proteins, Drug Resistance, Neoplasm, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 21-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.
- Biomedicine Research and Development Center, National Engineering Research Center of Genetic Medicine, Jinan University, Guangzhou, Guangdong 510632, China.
- The First-Affiliated Hospital, Jinan University, Guangzhou, Guangdong 510632, China.
Zitieren
APA
Hu, H. F., Han, L., Fu, J. Y., He, X., Tan, J. F., Chen, Q. P., Han, J. R., & He, Q. Y. (2024). LINC00982-encoded protein PRDM16-DT regulates CHEK2 splicing to suppress colorectal cancer metastasis and chemoresistance. Theranostics. https://doi.org/10.7150/thno.95485
Vancouver
Hu HF, Han L, Fu JY, He X, Tan JF, Chen QP, et al. LINC00982-encoded protein PRDM16-DT regulates CHEK2 splicing to suppress colorectal cancer metastasis and chemoresistance. Theranostics. 2024. doi:10.7150/thno.95485
BibTeX
@article{Hu2024,
author = {Hu, Hui-Fang and Han, Lei and Fu, Jia-Ying and He, Xuan and Tan, Ji-Feng and Chen, Qing-Ping and Han, Jing-Ru and He, Qing-Yu},
title = {LINC00982-encoded protein PRDM16-DT regulates CHEK2 splicing to suppress colorectal cancer metastasis and chemoresistance},
journal = {Theranostics},
year = {2024},
doi = {10.7150/thno.95485}
}
EUVIMED